The European Pharmacovigilance Congress is back, one of the key international events dedicated to drug safety surveillance. Here’s why we’ve chosen to take part again this year.
European Pharmacovigilance Congress 2025: the context
Scheduled from 19 to 28 November 2025, the European Pharmacovigilance Congress will take place in a hybrid format: two virtual days, 19 and 20 November, and one in-person day in Milan on 28 November, preceded by a networking evening and workshops on 27 November.
Organised by Pharma Education Center, the congress is recognised as one of the main international reference points for professionals working in drug safety, thanks to the high scientific quality of its content, the presence of leading experts, and a hands-on, practice-oriented approach.
The programme: key topics for those working in drug safety
The European Pharmacovigilance Congress provides a valuable opportunity to discuss core aspects of pharmacovigilance operations. The 2025 programme offers a clear reflection of today’s priorities.
19 November (virtual)
09:00 – 09:15 AM Welcome and opening of the conference
09:20 – 11:00 AM Advancing signal detection in pharmacovigilance: modern methodologies and best practices
11:00 – 11:20 AM Coffee break and networking
11:20 – 12:40 PM Risk management and, in parallel, Safety of combination products
12:40 – 1:45 PM Lunch and networking
1:45 – 3:20 PM Importance of real-world data sources and evidence beyond spontaneous reporting and, in parallel, Cosmetovigilance
3:20 – 3:40 PM Coffee break
3:40 – 5:20 PM Patients’ representatives contribution to pharmacovigilance and, in parallel, Non-EU pharmacovigilance requirements
5:20 – 5:25 PM Lectio magistralis
20 November (virtual)
09:00 – 09:10 AM Welcome and opening of the conference
09:10 – 10:45 AM Authorities review of pharmacovigilance data from clinical development to when things go wrong
10:45 – 11:05 AM Coffe break
11:05 – 12:40 PM Benefit/risk evaluation of medicinal products and, in parallel Labelling: a fundamental risk communication and minimization tool
12:40 – 1:45 PM Lunch
1:45 – 3:20 PM Regulatory aspects for implementing Artificial Intelligence in pharmacovigilance and, in parallel, Aggregate reports around the world
3:20 – 3:40 PM Coffee break
3:40 – 5:20 PM Immunologically driven adverse reactions and, in parallel, Practical examples of Artificial Iintelligence implementation in pharmacovigilance processes
28 November (in person, Milan)
08:30 – 09:30 AM Registration of attendees, welcome and opening of the conference
09:30 – 11:00 AM Overcoming challenges and prioritizing value in the evolving pharmacovigilance landscape
11:00 – 11:30 AM Coffee break and networking
11:30 – 1:00 PM Personalized pharmacovigilance and, in parallel, Workshop Pharmacovigilance in transition: adapting to global and regional regulatory change
1:15 – 2:15 PM Lunch and networking
2:15 – 3:20 PM PRAC and other European authority processes for monitoring the benefit risk of drugs and, in parallel, New skills needed in pharmacovigilance
3:20 – 3:45 PM Coffee break and networking
3:45 – 5:40 PM Pre and post marketing audits and inspections
Networking opportunities
This year’s edition will feature over 70 speakers, more than 400 attendees and 14 sponsors, including SafetyDrugs. We’ll be there to meet professionals in the field, discuss emerging challenges in drug safety management, and showcase our solution for post-marketing surveillance, a tool designed to support complex operations, ensure traceability, structure, and compliance, and help teams manage everyday tasks with greater confidence.
If you’re attending the congress, we invite you to stop by our stand. It will be a chance to explore how SafetyDrugs works and exchange ideas on how to keep improving pharmacovigilance processes.
